About GenapSys
GenapSys is a company based in Redwood City (United States) founded in 2010.. GenapSys has raised $313.03 million across 9 funding rounds from investors including HHS, Farallon Capital Management and Oxford Finance. The company has 60 employees as of December 31, 2022. GenapSys operates in a competitive market with competitors including Cepheid, Nanopore, PacBio, Fluidigm and Omniome, among others.
- Headquarter Redwood City, United States
- Employees 60 as on 31 Dec, 2022
-
Sectors
Retail
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genapsys
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$313.03 M (USD)
in 9 rounds
-
Latest Funding Round
$70 M (USD), Series D
Mar 01, 2021
-
Investors
HHS
& 8 more
-
Employee Count
60
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of GenapSys
GenapSys has successfully raised a total of $313.03M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $70 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series D — $70.0M
-
First Round
First Round
(01 Sep 2012)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series D - GenapSys | Valuation |
investors |
|
| Feb, 2020 | Amount | Series C - GenapSys | Valuation | Oxford Finance |
|
| Nov, 2019 | Amount | Series C - GenapSys | Valuation | Foresite Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenapSys
GenapSys has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include HHS, Farallon Capital Management and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenapSys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenapSys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genapsys Comparisons
Competitors of GenapSys
GenapSys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Nanopore, PacBio, Fluidigm and Omniome, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Instruments for life sciences research and applications are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genapsys
Frequently Asked Questions about GenapSys
When was GenapSys founded?
GenapSys was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is GenapSys located?
GenapSys is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is GenapSys a funded company?
GenapSys is a funded company, having raised a total of $313.03M across 9 funding rounds to date. The company's 1st funding round was a Series C of $90M, raised on Sep 01, 2012.
How many employees does GenapSys have?
As of Dec 31, 2022, the latest employee count at GenapSys is 60.
What does GenapSys do?
GenapSys was founded in 2010 and is based in Redwood City, United States. DNA sequencing technologies are offered by the company for applied genomic testing and medical sequencing within the biotechnology sector. A chip-based portable system called Gene Electronic Nano-Integrated Ultra-Sensitive has been developed for these purposes. Operations cover research, diagnostics, drug development, agriculture, forensics, and personal genomics.
Who are the top competitors of GenapSys?
Who are GenapSys's investors?
GenapSys has 9 investors. Key investors include HHS, Farallon Capital Management, Oxford Finance, Soleus Capital, and Foresite Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.